Immunome Reports Inducement Grants Under Nasdaq Rule
Immunome, Inc. announced that on October 1, 2026, the Compensation Committee of the Company’s Board of Directors approved inducement grants under Nasdaq Listing Rule 5635(c)(4).
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.